These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33472993)

  • 1. Inhibitory effect of PI3Kδ inhibitor idelalisib on proliferation of human myeloid leukemia cells and the reversal effect on drug resistance to adriamycin.
    Li K; Yi P; Luo H; Li J; Meng L; Tang M; Zeng W; Yang S; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1389-1397. PubMed ID: 33472993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin].
    Li BR; Wang L; Han WN; Xia LQ; Tang S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1369-1374. PubMed ID: 27784359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversal Effect of Arctigenin on the Drug Resistance in Leukemia K562/A02 Cells and Its Mechanism].
    Zou L; Fang Y; He W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):409-415. PubMed ID: 38660844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line.
    Zhai X; Lu J; Wang Y; Fang F; Li B; Gu W
    J Tradit Chin Med; 2014 Dec; 34(6):678-83. PubMed ID: 25618972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hypoxia inducible factor1-α inhibitor on reversal of multidrug resistance of K562/A02 cell line].
    Chen BA; Wang F; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Xia GH; Shan XY
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):389-93. PubMed ID: 21122354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
    Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of phenylhexyl isothiocyanate on adriamycin resistance of K562/A02 cell line].
    Yuang P; Chen BA; Cheng J; Ma XD; Liu DL; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):352-7. PubMed ID: 19379565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
    Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
    Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
    Wang Z; Zhou N; Zhao J; Zhang X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC25A40 Facilitates Anticancer Drug Resistance in Human Leukemia K562 Cells.
    Kudo N; Kouno R; Shibayama Y
    Biol Pharm Bull; 2023 Sep; 46(9):1304-1309. PubMed ID: 37407483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
    Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
    Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on reversing mechanism of multidrug resistance of K562/A02 cell line by carnosic acid].
    Yu XN; Li H; Chen XL; Li XX; Wang R; Gao F
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):381-4. PubMed ID: 21122352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversal of multidrug resistance by lomerizine in K562/ADM cells].
    Zhu HJ; Wu YL; Liu GQ
    Yao Xue Xue Bao; 2004 May; 39(5):333-7. PubMed ID: 15338873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑145 promotes the apoptosis of leukemic stem cells and enhances drug‑resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1.
    Wuxiao Z; Wang H; Su Q; Zhou H; Hu M; Tao S; Xu L; Chen Y; Hao X
    Int J Mol Med; 2020 Oct; 46(4):1289-1300. PubMed ID: 32945355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of desferrioxamine on K562/A02 cell line and its mechanism].
    Cheng J; Wang T; Chen BA; Ding JH; Gao C; Xia GH; Bao W; Song HH; Xu WL; Shen HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):337-41. PubMed ID: 21518484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal of Drug Resistance in K562/ADM Cells Caused by RA and the Related Mechanisms].
    Zhong SS; Yuan YP; Xin LY; Chen YJ; Zhang LQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1704-1709. PubMed ID: 34893097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.